Veradermics (MANE) Assets (2024 - 2026)

Veradermics (MANE) has 3 years of Assets data on file, last reported at $397.4 million in Q1 2026.

• Quarterly Assets changed N/A year-over-year to $397.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $397.4 million (changed N/A YoY) and the FY2025 annual result came in at $152.6 million, up 174.82% from the prior year.
• Assets improved to $397.4 million in Q1 2026, from $152.6 million in the prior quarter.
• In the past five years, Assets ranged from a high of $397.4 million in Q1 2026 to a low of $55.5 million in Q4 2024.
• A 3-year average of $201.8 million and a median of $152.6 million in 2025 frame the typical range for Assets.
• The widest YoY moves for Assets: up 174.82% in 2025, down 174.82% in 2025.
• Tracing MANE's Assets over 3 years: stood at $55.5 million in 2024, then soared by 174.82% to $152.6 million in 2025, then jumped by 160.36% to $397.4 million in 2026.
• The last three Assets figures came in at $397.4 million (Q1 2026), $152.6 million (Q4 2025), and $55.5 million (Q4 2024), per Business Quant data.